UPLOAD Filing
Liminatus Pharma, Inc.
Date: Jan. 6, 2026 · CIK: 0001971387 · Accession: 0000000000-26-000092
AI Filing Summary & Sentiment
Reasoning
Letter
January 6, 2026 Chris Kim Chief Executive Officer and Director Liminatus Pharma, Inc. 12611 Hiddencreek Way, Unit C Cerritos, CA 90703 Re:Liminatus Pharma, Inc. Draft Registration Statement on Form S-1 Submitted December 31, 2025 CIK No. 0001971387 Dear Chris Kim: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement and non-public draft submission on EDGAR at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Giovanni Caruso, Esq.
Show Raw Text
January 6, 2026
Chris Kim
Chief Executive Officer and Director
Liminatus Pharma, Inc.
12611 Hiddencreek Way, Unit C
Cerritos, CA 90703
Re:Liminatus Pharma, Inc.
Draft Registration Statement on Form S-1
Submitted December 31, 2025
CIK No. 0001971387
Dear Chris Kim:
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement and non-public draft
submission on EDGAR at least two business days prior to the requested effective date and
time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Giovanni Caruso, Esq.